Federal Register / Vol. 75, No. 63 / Friday, April 2, 2010 / Notices 16813 

Send comments to Summer King, 

SAMHSA Reports Clearance Officer, 

Room 7–1044, One Choke Cherry Road, 

Rockville, MD 20857 and e-mail her a 

copy at summer.king@samhsa.hhs.gov. 

Written comments should be received 

within 60 days of this notice. 

Dated: March 23, 2010. 

Elaine Parry, 

Director, Office of Program Services. 

[FR Doc. 2010–7432 Filed 4–1–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10197] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Evaluation of 

the Medicare National Competitive 

Bidding Program for DME; Use: Data 

collection materials consisting of 

beneficiary surveys and interview/ 

discussion group guides are necessary to 

conduct the congressionally mandated 

evaluation of the Medicare National 

Competitive Bidding Program. Section 

303(d) of the Medicare Prescription 

Drug, Improvement, and Modernization 

Act of 2003 (MMA) requires a Report to 

Congress on the program, covering 

program savings, reductions in cost 

sharing, impacts on access to and 

quality of affected goods and services, 

and beneficiary satisfaction. This 

project’s purpose is to provide 

information for this Report to Congress. 

Due to substantial legislative and 

regulatory delays in program 

implementation, the Report to Congress 

in 2011 will be released just as the 

program is being implemented, and 

before the evaluation is complete. This 

project will continue after the Report to 

Congress, to evaluate the impact of the 

program on beneficiaries, on Medicare 

costs, and on changes in the Medicare 

Durable Medical Equipment, 

Prosthetics, Orthotics and Supplies 

(DMEPOS) market. 

In response to public comments 

received on the 60-day notice that 

published on December 18, 2009 (74 FR 

67227), we have made several revisions 

to this information collection request. 

Most notably, the revisions include but 

are not limited to revised burden 

calculations due to an increase in the 

number of respondents and the addition 

of another data collection wave. Form 

Number: CMS–10197 (OMB#: 0938– 

1015); Frequency: Occasionally; 

Affected Public: Individuals or 

households, Private Sector, Business or 

other for-profits, not-for-profit 

institutions, and Federal Government; 

Number of Respondents: 8,470; Total 

Annual Responses: 8,470; Total Annual 

Hours: 4,342. (For policy questions 

regarding this collection contact Ann 

Meadow at 410–786–6602. For all other 

issues call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on May 3, 2010. 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS 

Desk Officer, Fax Number: (202) 395– 

6974, E-mail: 

OIRA_submission@omb.eop.gov. 

Dated: March 26, 2010. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2010–7469 Filed 4–1–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of Laboratories Which 

Meet Minimum Standards To Engage in 

Urine Drug Testing for Federal 

Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies Federal 

agencies of the laboratories currently 

certified to meet the standards of 

Subpart C of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines). The 

Mandatory Guidelines were first 

published in the Federal Register on 

April 11, 1988 (53 FR 11970), and 

subsequently revised in the Federal 

Register on June 9, 1994 (59 FR 29908), 

on September 30, 1997 (62 FR 51118), 

and on April 13, 2004 (69 FR 19644). 

A notice listing all currently certified 

laboratories is published in the Federal 

Register during the first week of each 

month. If any laboratory’s certification 

is suspended or revoked, the laboratory 

will be omitted from subsequent lists 

until such time as it is restored to full 

certification under the Mandatory 

Guidelines. 

If any laboratory has withdrawn from 

the HHS National Laboratory 

Certification Program (NLCP) during the 

past month, it will be listed at the end, 

and will be omitted from the monthly 

listing thereafter. 

This notice is also available on the 

Internet at http:// 

www.workplace.samhsa.gov and http:// 

www.drugfreeworkplace.gov. 

FOR FURTHER INFORMATION CONTACT: Mrs. 

Giselle Hersh, Division of Workplace 

Programs, SAMHSA/CSAP, Room 2– 

1042, One Choke Cherry Road, 

Rockville, Maryland 20857; 240–276– 

2600 (voice), 240–276–2610 (fax). 

SUPPLEMENTARY INFORMATION: The 

Mandatory Guidelines were developed 

in accordance with Executive Order 

12564 and section 503 of Public Law 

100–71. Subpart C of the Mandatory 

Guidelines, ‘‘Certification of 

mstockstill on DSKH9S0YB1PROD with NOTICES